Publication:

Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection

Date

Date

Date
2024
Journal Article
Published version

Citations

Citation copied

Abela, I. A., Schwarzmüller, M., Ulyte, A., Radtke, T., Haile, S. R., Ammann, P., Raineri, A., Rueegg, S., Epp, S., Berger, C., Böni, J., Manrique, A., Audigé, A., Huber, M., Schreiber, P. W., Scheier, T., Fehr, J., Weber, J., Rusert, P., … Pasin, C. (2024). Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection. MBio, 15, e0272223. https://doi.org/10.1128/mbio.02722-23

Abstract

Abstract

Abstract

Knowledge of the interplay between human coronavirus (HCoV) immunity and severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection is critical to understanding the coexistence of current endemic coronaviruses and to building knowledge potential future zoonotic coronavirus transmissions. This study, which retrospectively analyzed a large cohort of individuals first exposed to SARS-CoV-2 in Switzerland in 2020–2021, revealed several key findings. Pre-existing HCoV immunity, particularly mucosal antibody responses, play

Metrics

Downloads

29 since deposited on 2024-03-27
Acq. date: 2025-11-12

Views

69 since deposited on 2024-03-27
Acq. date: 2025-11-12

Additional indexing

Creators (Authors)

Journal/Series Title

Journal/Series Title

Journal/Series Title

Volume

Volume

Volume
15

Number

Number

Number
2

Page range/Item number

Page range/Item number

Page range/Item number
e0272223

Item Type

Item Type

Item Type
Journal Article

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Keywords

Virology, Microbiology

Language

Language

Language
English

Publication date

Publication date

Publication date
2024-01-25

Date available

Date available

Date available
2024-03-27

Publisher

Publisher

Publisher

ISSN or e-ISSN

ISSN or e-ISSN

ISSN or e-ISSN
2150-7511

OA Status

OA Status

OA Status
Gold

Free Access at

Free Access at

Free Access at
DOI

PubMed ID

PubMed ID

PubMed ID

Metrics

Downloads

29 since deposited on 2024-03-27
Acq. date: 2025-11-12

Views

69 since deposited on 2024-03-27
Acq. date: 2025-11-12

Citations

Citation copied

Abela, I. A., Schwarzmüller, M., Ulyte, A., Radtke, T., Haile, S. R., Ammann, P., Raineri, A., Rueegg, S., Epp, S., Berger, C., Böni, J., Manrique, A., Audigé, A., Huber, M., Schreiber, P. W., Scheier, T., Fehr, J., Weber, J., Rusert, P., … Pasin, C. (2024). Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection. MBio, 15, e0272223. https://doi.org/10.1128/mbio.02722-23

Gold Open Access
Loading...
Thumbnail Image

Files

Files

Files
Files available to download:1

Files

Files

Files
Files available to download:1
Loading...
Thumbnail Image